Homeopathic treatment of children with attention deficit disorder: a randomized, double blind, placebo-controlled crossover trial. H. Frei R. Everts, K.v. Ammon et al. Eur J Pediatr. 2005; 164: 758-767. - Suppr | 超能文献

Homeopathic treatment of children with attention deficit disorder: a randomized, double blind, placebo-controlled crossover trial. H. Frei R. Everts, K.v. Ammon et al. Eur J Pediatr. 2005; 164: 758-767.

作者信息

Adler Rolf H, Herschkowitz Norbert, Minder Christoph E

出版信息

Eur J Pediatr. 2007 May;166(5):509. doi: 10.1007/s00431-006-0262-5. Epub 2006 Sep 19.

DOI:10.1007/s00431-006-0262-5

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Homeopathic treatment of children with attention deficit disorder: a randomized, double blind, placebo-controlled crossover trial. H. Frei R. Everts, K.v. Ammon et al. Eur J Pediatr. 2005; 164: 758-767.

Eur J Pediatr. 2007 May;166(5):509. doi: 10.1007/s00431-006-0262-5. Epub 2006 Sep 19.

2

Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial.顺势疗法治疗注意缺陷多动障碍儿童：一项随机、双盲、安慰剂对照交叉试验。

Eur J Pediatr. 2005 Dec;164(12):758-67. doi: 10.1007/s00431-005-1735-7. Epub 2005 Jul 27.

3

Randomised controlled trials of homeopathy in hyperactive children: treatment procedure leads to an unconventional study design. Experience with open-label homeopathic treatment preceding the Swiss ADHD placebo controlled, randomised, double-blind, cross-over trial.顺势疗法治疗多动症儿童的随机对照试验：治疗程序导致了一种非常规的研究设计。瑞士多动症安慰剂对照、随机、双盲、交叉试验之前的开放标签顺势疗法治疗经验。

Homeopathy. 2007 Jan;96(1):35-41. doi: 10.1016/j.homp.2006.11.004.

4

Homeopathy for attention-deficit/hyperactivity disorder: a pilot randomized-controlled trial.顺势疗法治疗注意力缺陷/多动障碍：一项初步随机对照试验。

J Altern Complement Med. 2005 Oct;11(5):799-806. doi: 10.1089/acm.2005.11.799.

5

Treatment of hyperactive children: increased efficiency through modifications of homeopathic diagnostic procedure.多动症儿童的治疗：通过改进顺势疗法诊断程序提高效率。

Homeopathy. 2006 Jul;95(3):119-20. doi: 10.1016/j.homp.2006.05.003.

6

Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial.托莫西汀治疗增强了未经药物治疗的注意力缺陷多动障碍成年患者大脑功能网络之间的反相关关系：一项随机双盲安慰剂对照临床试验。

Int J Neuropsychopharmacol. 2015 Sep 16;19(3):pyv094. doi: 10.1093/ijnp/pyv094.

7

An open-label pilot study of homeopathic treatment of attention deficit hyperactivity disorder in children and youth.一项关于顺势疗法治疗儿童和青少年注意力缺陷多动障碍的开放标签试验性研究。

Forsch Komplementmed. 2014;21(5):302-9. doi: 10.1159/000368137. Epub 2014 Sep 19.

8

Methodological difficulties in homeopathic treatment of children with ADD/ADHD.顺势疗法治疗注意缺陷多动障碍（ADD/ADHD）患儿的方法学难题。

J Altern Complement Med. 2006 Mar;12(2):104; author reply 104. doi: 10.1089/acm.2006.12.104.

9

The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.硫酸右苯丙胺（Evekeo）治疗注意力缺陷/多动障碍症状的疗效与安全性：一项多中心、剂量优化、双盲、随机、安慰剂对照的交叉实验室课堂研究。

J Child Adolesc Psychopharmacol. 2015 Jun;25(5):402-14. doi: 10.1089/cap.2014.0176. Epub 2015 Feb 18.

10

A double-blind, randomized, placebo/active controlled crossover evaluation of the efficacy and safety of Ritalin ® LA in children with attention-deficit/hyperactivity disorder in a laboratory classroom setting.在实验室教室环境中，对患有注意力缺陷/多动障碍的儿童进行的一项关于利他林长效制剂（Ritalin® LA）疗效和安全性的双盲、随机、安慰剂/活性对照交叉评估。

J Child Adolesc Psychopharmacol. 2010 Oct;20(5):377-85. doi: 10.1089/cap.2009.0106.

引用本文的文献

1

What is the best available evidence for using homeopathy in patients with intellectual disabilities?在智障患者中使用顺势疗法的最佳现有证据是什么？

Iran J Pediatr. 2014 Aug;24(4):339-44. Epub 2014 Jul 4.

2

The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers.甲基转移酶EZH2并非乳腺癌发展所必需，尽管EZH2水平高和H3K27me3水平低与雌激素受体阳性乳腺癌的不良预后相关。

Mol Carcinog. 2015 Oct;54(10):1172-80. doi: 10.1002/mc.22188. Epub 2014 Jul 7.